INR 136.15
(-0.26%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 569.18 Million INR | 33.55% |
2022 | 426.2 Million INR | -7.83% |
2021 | 462.4 Million INR | -6.81% |
2020 | 496.2 Million INR | 69.61% |
2019 | 292.55 Million INR | 59.77% |
2018 | 183.11 Million INR | 11.18% |
2017 | 164.7 Million INR | 2.07% |
2016 | 161.37 Million INR | 17.14% |
2015 | 137.76 Million INR | -4.8% |
2014 | 144.71 Million INR | -20.13% |
2013 | 181.17 Million INR | 10.17% |
2012 | 164.44 Million INR | -9.75% |
2011 | 182.21 Million INR | 1.66% |
2010 | 179.23 Million INR | 8.93% |
2009 | 164.53 Million INR | 43.0% |
2008 | 115.06 Million INR | 31.4% |
2007 | 87.56 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 367 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 474.76 Million INR | 0.0% |
2023 FY | 569.18 Million INR | 33.55% |
2023 Q4 | 569.18 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q4 | 426.2 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 FY | 426.2 Million INR | -7.83% |
2022 Q2 | 448.25 Million INR | 0.0% |
2021 Q4 | 462.4 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 462.4 Million INR | -6.81% |
2021 Q2 | 469.56 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 496.2 Million INR | 69.61% |
2020 Q2 | 323.13 Million INR | 0.0% |
2020 Q4 | 496.2 Million INR | 0.0% |
2019 Q4 | 292.55 Million INR | 0.0% |
2019 FY | 292.55 Million INR | 59.77% |
2019 Q2 | 307.79 Million INR | 0.0% |
2018 Q4 | 183.11 Million INR | 0.0% |
2018 Q2 | 169.13 Million INR | 0.0% |
2018 FY | 183.11 Million INR | 11.18% |
2017 Q2 | 193.9 Million INR | 0.0% |
2017 FY | 164.7 Million INR | 2.07% |
2017 Q4 | 164.7 Million INR | 0.0% |
2016 FY | 161.37 Million INR | 17.14% |
2016 Q2 | 146.61 Million INR | 0.0% |
2016 Q4 | 153.85 Million INR | 0.0% |
2015 Q2 | 161.28 Million INR | 0.0% |
2015 Q4 | 137.76 Million INR | 0.0% |
2015 FY | 137.76 Million INR | -4.8% |
2014 FY | 144.71 Million INR | -20.13% |
2014 Q4 | 144.71 Million INR | 0.0% |
2014 Q2 | 162.98 Million INR | 0.0% |
2013 Q2 | 138.81 Million INR | 0.0% |
2013 Q4 | 181.17 Million INR | 0.0% |
2013 FY | 181.17 Million INR | 10.17% |
2012 Q4 | 164.44 Million INR | 0.0% |
2012 FY | 164.44 Million INR | -9.75% |
2011 FY | 182.21 Million INR | 1.66% |
2011 Q4 | 182.21 Million INR | 0.0% |
2010 FY | 179.23 Million INR | 8.93% |
2009 FY | 164.53 Million INR | 43.0% |
2008 FY | 115.06 Million INR | 31.4% |
2007 FY | 87.56 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Add-Shop E-Retail Limited | 159.2 Million INR | -257.516% |
Cian Healthcare Limited | 1.03 Billion INR | 44.972% |
Chemo Pharma Laboratories Limited | 2.12 Million INR | -26647.18% |
Colinz Laboratories Limited | 24.1 Million INR | -2261.253% |
Denis Chem Lab Limited | 289.82 Million INR | -96.39% |
Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -4146.028% |
Evoq Remedies Limited | 116.23 Million INR | -389.693% |
Gujarat Themis Biosyn Limited | 197.37 Million INR | -188.378% |
Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -182.343% |
MedPlus Health Services Limited | 14.27 Billion INR | 96.013% |
OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 31.683% |
PANJON LTD. | 25.38 Million INR | -2142.367% |
PRAVEG LIMITED | 767.53 Million INR | 25.843% |
Sanjivani Paranteral Limited. | 155.06 Million INR | -267.059% |
Sastasundar Ventures Limited | 1.5 Billion INR | 62.07% |
SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -190261.204% |
SHELTER PHARMA LIMITED | 20.99 Million INR | -2611.672% |
BDH Industries Limited | 312.53 Million INR | -82.117% |
DECIPHER LABS LIMITED | 117.72 Million INR | -383.483% |
ANG Lifesciences India Limited | 1.66 Billion INR | 65.745% |
Veerhealth Care Limited | 62.78 Million INR | -806.626% |
Zenith Healthcare Limited | 24.03 Million INR | -2268.13% |
Zenlabs Ethica Limited | 301.35 Million INR | -88.874% |
Zenotech Laboratories Limited | 156.64 Million INR | -263.35% |
Crestchem Limited | 23.94 Million INR | -2276.832% |
Norris Medicines Limited | 278.17 Million INR | -104.614% |
Shukra Pharmaceuticals Limited | 201.97 Million INR | -181.809% |
Sunil Healthcare Limited | 902.83 Million INR | 36.956% |
Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 49.67% |
Bacil Pharma Limited | 1.12 Million INR | -50314.526% |
Fredun Pharmaceuticals Limited | 1.86 Billion INR | 69.42% |
Patidar Buildcon Limited | 25.57 Million INR | -2125.794% |
Phaarmasia Limited | 211.49 Million INR | -169.122% |
Shree Ganesh Remedies Limited | 488.36 Million INR | -16.547% |
SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 66.796% |
Trimurthi Limited | 101.36 Thousand INR | -561443.015% |
Vista Pharmaceuticals Limited | 175.16 Million INR | -224.936% |
Vivanza Biosciences Limited | 148.63 Million INR | -282.948% |
Hindustan Bio Sciences Limited | 25.7 Million INR | -2114.616% |
Anuh Pharma Limited | 1.54 Billion INR | 63.151% |
Beryl Drugs Limited | 85.63 Million INR | -564.65% |
Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 43.327% |
Deccan Health Care Limited | 111.33 Million INR | -411.227% |
Godavari Drugs Limited | 957.86 Million INR | 40.578% |
Gujarat Terce Laboratories Limited | 161.67 Million INR | -252.054% |
Ishita Drugs and Industries Limited | 8.87 Million INR | -6315.464% |
Kerala Ayurveda Limited | 1.05 Billion INR | 46.184% |
KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 42.874% |
Lactose (India) Limited | 536.39 Million INR | -6.112% |
Medi-Caps Limited | 63.01 Million INR | -803.231% |
Mercury Laboratories Limited | 171.18 Million INR | -232.486% |
Parmax Pharma Limited | 117.56 Million INR | -384.13% |
Roopa Industries Limited | 493.08 Million INR | -15.432% |
Smruthi Organics Limited | 485.72 Million INR | -17.183% |
Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -1256.095% |
Syschem (India) Limited | 1.07 Billion INR | 46.841% |
Vikram Thermo (India) Limited | 291.47 Million INR | -95.275% |
Bharat Parenterals Limited | 2.65 Billion INR | 78.574% |
Trident Lifeline Limited | 331.26 Million INR | -71.822% |
Concord Drugs Limited | 249.88 Million INR | -127.776% |
Gennex Laboratories Limited | 535.21 Million INR | -6.347% |
TIAAN CONSUMER LIMITED | 14.97 Million INR | -3699.853% |
Vasundhara Rasayans Limited | 53.64 Million INR | -960.973% |
Parnax Lab Limited | 1.17 Billion INR | 51.382% |
Trinity League India Limited | 876 Thousand INR | -64874.886% |
Sandu Pharmaceuticals Limited | 118.22 Million INR | -381.446% |
Tyche Industries Limited | 101.64 Million INR | -459.991% |
Kwality Pharmaceuticals Limited | 1.71 Billion INR | 66.836% |
Transchem Limited | 6.72 Million INR | -8369.94% |
Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -173.065% |
Panchsheel Organics Limited | 340.2 Million INR | -67.306% |
Coral Laboratories Limited | 281.83 Million INR | -101.952% |
KOBO BIOTECH LIMITED | 2.04 Billion INR | 72.141% |
Natural Capsules Limited | 1.47 Billion INR | 61.469% |
Auro Laboratories Limited | 433.09 Million INR | -31.421% |